IGRA, a revolutionary new technology, has enabled healthcare professionals to screen a patient for possible TB through the testing of a standard blood sample.
IGRA’s are an efficient, convenient, and accurate way to test for evidence of an immune response to TB. Test results are available sooner with better sensitivity and specificity, while cutting office visits required for testing in half.
Access this white paper to explore the facts and debunk the myths that have surrounded IGRAs since their inception nearly 2 decades ago.
By downloading this resource, I agree to sign up to receive newsletters and special offers from HealthLeaders and the sponsor. I understand that I can opt-out at any time. Privacy policy.